Physician profile
Daniel L Moon
NPI 1922268705
$1,687.99
in general payments reported to CMS, 2019-2025
14 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $143 · 2021: $240 · 2022: $224 · 2023: $180 · 2024: $349 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $539.72 | 2021-2025 | Signia, Ligasure, Versaone |
| Intuitive Surgical, INC. | $290.10 | 2020-2024 | Da Vinci Surgical System |
| Endo Pharmaceuticals INC. | $222.18 | 2019-2022 | |
| Ethicon US, LLC | $127.15 | 2019-2024 | Echelon Endopath |
| Depuy Synthes Sales INC. | $100.68 | 2020-2025 | Motoband, Hammerlock |
| Integra Lifesciences Corporation | $93.96 | 2021-2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $74.32 | 2019 | |
| Acell, INC. | $64.76 | 2019 | |
| Baxter Healthcare | $57.55 | 2019-2022 | |
| Teleflex LLC | $26.66 | 2023 | Titan Sgs Standard Gastric Stapler |
| Covidien Lp | $24.08 | 2019 | |
| Fresenius Kabi USA, LLC | $23.91 | 2025 | Tyenne |
| Organogenesis INC. | $22.93 | 2023 | Puraply |
| Merck Sharp & Dohme LLC | $19.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.